RIGEL PHARMACEUTICALS, INC. Variable Lease, Cost
RIGEL PHARMACEUTICALS, INC. (RIGL) reported Variable Lease, Cost of $71.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-03-03
- RIGEL PHARMACEUTICALS, INC. variable lease, cost for the quarter ending 2025-12-31 was $22.00K, a 21.43% decline year-over-year.
- RIGEL PHARMACEUTICALS, INC. variable lease, cost for the quarter ending 2025-09-30 was $14.00K, a 50.00% decline year-over-year.
- RIGEL PHARMACEUTICALS, INC. variable lease, cost for the quarter ending 2025-06-30 was $18.00K, a 35.71% decline year-over-year.
- RIGEL PHARMACEUTICALS, INC. variable lease, cost for the quarter ending 2025-03-31 was $17.00K, a 39.29% decline year-over-year.
- RIGEL PHARMACEUTICALS, INC. variable lease, cost for fiscal 2025 was $71.00K, a 36.61% decline from fiscal 2024.
- RIGEL PHARMACEUTICALS, INC. variable lease, cost for fiscal 2024 was $112.00K, a 16.42% decline from fiscal 2023.
- RIGEL PHARMACEUTICALS, INC. variable lease, cost for fiscal 2023 was $134.00K, a 83.62% decline from fiscal 2022.
- RIGEL PHARMACEUTICALS, INC. variable lease, cost for fiscal 2022 was $818.00K, a 10.11% decline from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $36.00K derived: sum of 2 quarters · filed 2026-03-03 | $54.00K derived: sum of 3 quarters · filed 2026-03-03 | $71.00K 10-K · filed 2026-03-03 |
| 2025-09-30 | $14.00K 10-Q · filed 2025-11-04 | $32.00K derived: sum of 2 quarters · filed 2025-11-04 | $49.00K 10-Q · filed 2025-11-04 | $77.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2025-06-30 | $18.00K 10-Q · filed 2025-08-05 | $35.00K 10-Q · filed 2025-08-05 | $63.00K derived: sum of 3 quarters · filed 2026-03-03 | $91.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2025-03-31 | $17.00K 10-Q · filed 2025-05-06 | $45.00K derived: sum of 2 quarters · filed 2026-03-03 | $73.00K derived: sum of 3 quarters · filed 2026-03-03 | $101.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-12-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $56.00K derived: sum of 2 quarters · filed 2026-03-03 | $84.00K derived: sum of 3 quarters · filed 2026-03-03 | $112.00K 10-K · filed 2026-03-03 |
| 2024-09-30 | $28.00K 10-Q · filed 2025-11-04 | $56.00K derived: sum of 2 quarters · filed 2025-11-04 | $84.00K 10-Q · filed 2025-11-04 | $113.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-30 | $28.00K 10-Q · filed 2025-08-05 | $56.00K 10-Q · filed 2025-08-05 | $85.00K derived: sum of 3 quarters · filed 2026-03-03 | $160.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-03-31 | $28.00K 10-Q · filed 2025-05-06 | $57.00K derived: sum of 2 quarters · filed 2026-03-03 | $132.00K derived: sum of 3 quarters · filed 2026-03-03 | $90.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2023-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $104.00K derived: sum of 2 quarters · filed 2026-03-03 | $62.00K derived: sum of 3 quarters · filed 2026-03-03 | $134.00K 10-K · filed 2026-03-03 |
| 2023-09-30 | $75.00K 10-Q · filed 2024-11-07 | $33.00K derived: sum of 2 quarters · filed 2024-11-07 | $105.00K 10-Q · filed 2024-11-07 | $321.00K derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-06-30 | -$42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $30.00K 10-Q · filed 2024-08-06 | $246.00K derived: sum of 3 quarters · filed 2025-03-04 | $457.00K derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-03-31 | $72.00K 10-Q · filed 2024-05-07 | $288.00K derived: sum of 2 quarters · filed 2025-03-04 | $499.00K derived: sum of 3 quarters · filed 2025-03-04 | $624.00K derived: sum of 4 quarters · filed 2025-03-04 |
| 2022-12-31 | $216.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $427.00K derived: sum of 2 quarters · filed 2025-03-04 | $552.00K derived: sum of 3 quarters · filed 2025-03-04 | $818.00K 10-K · filed 2025-03-04 |
| 2022-09-30 | $211.00K 10-Q · filed 2023-11-07 | $336.00K derived: sum of 2 quarters · filed 2023-11-07 | $602.00K 10-Q · filed 2023-11-07 | $861.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | $125.00K 10-Q · filed 2022-08-02 | $391.00K 10-Q · filed 2022-08-02 | $650.00K derived: sum of 3 quarters · filed 2024-03-05 | $909.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | $266.00K 10-Q · filed 2023-05-02 | $525.00K derived: sum of 2 quarters · filed 2024-03-05 | $784.00K derived: sum of 3 quarters · filed 2024-03-05 | $947.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | $259.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $518.00K derived: sum of 2 quarters · filed 2024-03-05 | $681.00K derived: sum of 3 quarters · filed 2024-03-05 | $910.00K 10-K · filed 2024-03-05 |
| 2021-09-30 | $259.00K 10-Q · filed 2022-11-03 | $422.00K derived: sum of 2 quarters · filed 2022-11-03 | $651.00K 10-Q · filed 2022-11-03 | $873.00K derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-06-30 | $163.00K 10-Q · filed 2022-08-02 | $392.00K 10-Q · filed 2022-08-02 | $614.00K derived: sum of 3 quarters · filed 2023-03-07 | $851.00K derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-03-31 | $229.00K 10-Q · filed 2022-05-03 | $451.00K derived: sum of 2 quarters · filed 2023-03-07 | $688.00K derived: sum of 3 quarters · filed 2023-03-07 | $904.00K derived: sum of 4 quarters · filed 2023-03-07 |
| 2020-12-31 | $222.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $459.00K derived: sum of 2 quarters · filed 2023-03-07 | $675.00K derived: sum of 3 quarters · filed 2023-03-07 | $926.00K 10-K · filed 2023-03-07 |
| 2020-09-30 | $237.00K 10-Q · filed 2021-11-02 | $453.00K derived: sum of 2 quarters · filed 2021-11-02 | $704.00K 10-Q · filed 2021-11-02 | $829.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $216.00K 10-Q · filed 2021-08-03 | $467.00K 10-Q · filed 2021-08-03 | $592.00K derived: sum of 3 quarters · filed 2022-03-01 | $834.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $251.00K 10-Q · filed 2021-05-05 | $376.00K derived: sum of 2 quarters · filed 2022-03-01 | $618.00K derived: sum of 3 quarters · filed 2022-03-01 | $747.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $367.00K derived: sum of 2 quarters · filed 2022-03-01 | $496.00K derived: sum of 3 quarters · filed 2022-03-01 | $745.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | $242.00K 10-Q · filed 2019-11-05 | $371.00K derived: sum of 2 quarters · filed 2019-11-05 | $620.00K 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $129.00K 10-Q · filed 2019-08-06 | $378.00K 10-Q · filed 2019-08-06 | ||
| 2019-03-31 | $249.00K 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |